Cargando…
Appraisal of Experimental Methods to Manage Menopause and Infertility: Intraovarian Platelet-Rich Plasma vs. Condensed Platelet-Derived Cytokines
The first published description of intraovarian platelet-rich plasma (PRP) appeared in mid-2016, when a new experimental technique was successfully used in adult human ovaries to correct the reduced fertility potential accompanying advanced maternal age. Considering the potential therapeutic scope o...
Autores principales: | Sills, E. Scott, Wood, Samuel H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779970/ https://www.ncbi.nlm.nih.gov/pubmed/35056311 http://dx.doi.org/10.3390/medicina58010003 |
Ejemplares similares
-
Multichannel Recovery Potential with Activated Autologous Intraovarian Platelet-Rich Plasma and Its Derivatives
por: Sills, E. Scott, et al.
Publicado: (2023) -
Growth factors, gene activation, and cell recruitment: From intraovarian condensed platelet cytokines to de novo oocyte development
por: Sills, E. Scott, et al.
Publicado: (2022) -
mTOR Inhibition via Low-Dose, Pulsed Rapamycin with Intraovarian Condensed Platelet Cytokines: An Individualized Protocol to Recover Diminished Reserve?
por: Sills, E. Scott, et al.
Publicado: (2023) -
Progress in human ovarian rejuvenation: Current platelet-rich plasma and condensed cytokine research activity by scope and international origin
por: Sills, E. Scott, et al.
Publicado: (2021) -
Intraovarian injection of platelet-rich plasma in assisted reproduction: too much too soon?
por: Atkinson, Lloyd, et al.
Publicado: (2021)